AXXE - Axxess Pharma, Inc. DD

AXXE - Axxess Pharma, Inc.



AXXE Company Description
Axxess Pharma: a focused healthcare company dedicated to providing a wide range of products to improve the lives of patients and consumers worldwide.

We believe action defines leadership.

Our 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy.
Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to our company Business Plan. We balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE.


AXXE Products and Services
Axxess has a wide range of specialized healthcare products. Products will be launched based on priority and market demand.

Specialized products include:

-Specialized vitamins
-All natural pain relief
-Diabetes-specific supplements
-Pain relief supplements
-Hot/cold therapy

Prescription Products
Britical
Vivol
Gravergol
Soropon
Somnol
Kemsol
Lactrose
Niaxx
Urasal
Monurol
Axspaz
Hydraxx

Non-Prescription Products
Triferex Syrup Hydraxx 2%
Triferex Pediatric Syrup Hydraxx Serum
Potassium Chloride liquid Hydraxx Serum Eyes
Calcium Citrate with VitaminD Kemsol for Scleroderma
Soropon Shampoo Triferex Capsules
Hydraxx 1%

http://www.axxesspharmainc.com/products.php

AXXE Key Company Management
Daniel Bagi, M.D., President
Daniel Bagi, M.D. is a senior executive physician with 20+ year’s international experience in the medical device/pharmaceutical industry, with an emphasis on Product Development, Business Development and licensing. Expertise in product development as it pertains to clinical development for commercial use; medical affairs and clinical research, specifically oncology and gynecologic topical women’s health products. Good knowledge of international regulatory standards. Secured numerous license deals internationally, between North American pharma companies and local partners. Extensive experience presenting to financial institutions, regulatory agencies, and potential pharmaceutical partners.

AXXE Contact Info
Axxess Pharma Inc.
20 Valleywood Drive
Unit 105
Markham, ON L3R 6G1
Canada - Map
Phone: 905-513-0000
Fax: 905-513-1040
Website: http://www.axxesspharma.com

AXXE SEC Filings
http://www.otcmarkets.com/stock/AXXE/filings


AXXE Headlines
http://finance.yahoo.com/q/h?s=AXXE+Headlines


Investigate more about AXXE @ http://www.otcmarkets.com/stock/AXXE/quote for more due diligence.



Growth Plan
Products will distributed in mass retail across the following regions:
Canada - Currently in market
USA – Fall of 2014
Mexico – Fall of 2015
Target mass retailers to include: Walmart, Shoppers Drug Mart, CVS, Rexall, Walgreens, Pharmacia del la oro.

Axxess Pharma Inc. $AXXE - Video VNN - Daniel Bagi MD
http://www.youtube.com/watch?v=IfdFiNelN3c